Related Experiment Video
Updated: Feb 19, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Moving toward consensus on diagnosis and management of severe asthma in children
Désirée Larenas-Linnemann1, Antonio Nieto2, Oscar Palomares3
1a Investigational Unit, Hospital Medica Sur , Mexico City , Mexico.
Insights
Severe asthma in children remains challenging despite treatment. This review harmonizes understanding of pediatric severe asthma, focusing on phenotypes, diagnosis, and targeted therapies for better management.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Respiratory Medicine
Background:
- Severe asthma in children often persists despite high-dose corticosteroid therapy.
- Asthma's heterogeneity and diverse phenotypes complicate treatment strategies.
- Current understanding of pediatric severe asthma lacks consensus on key aspects.
Purpose of the Study:
- To provide a harmonized overview of severe asthma in children.
- To clarify definitions, phenotypes, and diagnostic approaches.
- To review current and future treatment and prevention strategies.
Main Methods:
- Literature review and synthesis of current research.
- Analysis of diagnostic criteria and phenotype identification.
- Examination of inflammatory pathways and therapeutic interventions.
Main Results:
- Severe pediatric asthma requires precise definitions and phenotype identification for targeted therapy.
- Understanding causal factors and improving diagnostic accuracy are crucial.
- Advancements in treatment and prevention strategies are needed.
Conclusions:
- A unified approach to defining and phenotyping severe pediatric asthma is essential.
- Improved diagnostic accuracy and targeted therapies can enhance patient outcomes.
- Further research is needed to optimize management and prevention of childhood severe asthma.
Abstract:
Children with severe asthma continue to experience symptoms despite long-term treatment with high doses of corticosteroids. Moreover, the heterogeneous nature of asthma and the presence of several phenotypes have limited our ability to develop an optimized management strategy for these patients. Adequate management of severe asthma in children necessitates a detailed understanding of what makes asthma difficult to control, knowledge of the causal factors, review of diagnosis for accurate identification of pediatric patients with severe asthma and a precise definition of the phenotypes to be able to better target the therapy. Advancement in all these aspects is likely to improve childhood asthma treatment in the future. Although our understanding of severe pediatric asthma has grown in recent years, there remains a lack of consensus and clarity around critical aspects of this condition. This review attempts to present a harmonized view on the definition of severe asthma in the pediatric age group, identification of phenotypes and diagnosis, the inflammatory cascade, pharmacological and non-pharmacological treatment strategies, considerations for follow-up and referral to specialists, and disease prevention strategies.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
05:50International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Asthma-IV: Nursing Management
First, in...
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...